메뉴 건너뛰기




Volumn 53, Issue 3, 2012, Pages 170-175

A multicenter study design to assess the clinical usefulness of semi-automatic measurement of flow-mediated vasodilatation of the brachial artery

(23)  Tomiyama, Hirofumi a   Kohro, Takahide b   Higashi, Yukihito c   Takase, Bonpei d   Suzuki, Toru b   Ishizu, Tomoko e   Ueda, Shinichiro f   Yamazaki, Tsutomu g   Furumoto, Tomoo h   Kario, Kazuomi i   Inoue, Teruo j   Koba, Shinji k   Watanabe, Kentaro l   Takemoto, Yasuhiko m   Hano, Takuzo n   Sata, Masataka o   Ishibashi, Yutaka p   Node, Koichi q   Maemura, Koji r   Ohya, Yusuke s   more..


Author keywords

Carotid atherosclerosis; Coronary artery disease; Endothelium; Flow mediated vasodilatation; Hypertension

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID;

EID: 84863470789     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.53.170     Document Type: Article
Times cited : (58)

References (18)
  • 1
    • 33845902544 scopus 로고    scopus 로고
    • The cardiovascular disease continuum validated: Clinical evidence of improved patient outcomes: Part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease)
    • (Review)
    • Dzau VJ, Antman EM, Black HR, et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation 2006; 114: 2850-70. (Review)
    • (2006) Circulation , vol.114 , pp. 2850-2870
    • Dzau, V.J.1    Antman, E.M.2    Black, H.R.3
  • 2
    • 33845882230 scopus 로고    scopus 로고
    • The cardiovascular disease continuum validated: Clinical evidence of improved patient outcomes: Part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions
    • (Review)
    • Dzau VJ, Antman EM, Black HR, et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions. Circulation 2006; 114: 2871-91. (Review)
    • (2006) Circulation , vol.114 , pp. 2871-2891
    • Dzau, V.J.1    Antman, E.M.2    Black, H.R.3
  • 3
    • 33947716172 scopus 로고    scopus 로고
    • Endothelial function and dysfunction: Testing and clinical relevance
    • (Review)
    • Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007; 115: 1285-95. (Review)
    • (2007) Circulation , vol.115 , pp. 1285-1295
    • Deanfield, J.E.1    Halcox, J.P.2    Rabelink, T.J.3
  • 4
    • 75549091472 scopus 로고    scopus 로고
    • Bench-to-bedside review: Nitric oxide in critical illness--update 2008
    • (Review)
    • Hollenberg SM, Cinel I. Bench-to-bedside review: nitric oxide in critical illness--update 2008. Crit Care 2009; 13: 218. (Review)
    • (2009) Crit Care , vol.13 , pp. 218
    • Hollenberg, S.M.1    Cinel, I.2
  • 5
    • 61449136198 scopus 로고    scopus 로고
    • Non-invasive diagnostic tools for investigating endothelial dysfunction
    • (Review)
    • Ghiadoni L, Versari D, Giannarelli C, Faita F, Taddei S. Non-invasive diagnostic tools for investigating endothelial dysfunction. Curr Pharm Des 2008; 14: 3715-22. (Review)
    • (2008) Curr Pharm Des , vol.14 , pp. 3715-3722
    • Ghiadoni, L.1    Versari, D.2    Giannarelli, C.3    Faita, F.4    Taddei, S.5
  • 6
    • 69449105430 scopus 로고    scopus 로고
    • Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: The multi-ethnic study of atherosclerosis
    • Yeboah J, Folsom AR, Burke GL, et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 2009; 120: 502-9.
    • (2009) Circulation , vol.120 , pp. 502-509
    • Yeboah, J.1    Folsom, A.R.2    Burke, G.L.3
  • 7
    • 77949557153 scopus 로고    scopus 로고
    • Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis
    • (Review)
    • Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55: 1318-27. (Review)
    • (2010) J Am Coll Cardiol , vol.55 , pp. 1318-1327
    • Vlachopoulos, C.1    Aznaouridis, K.2    Stefanadis, C.3
  • 8
    • 33745004785 scopus 로고    scopus 로고
    • Biomarkers of cardiovascular disease: Molecular basis and practical considerations
    • (Review)
    • Vasan RS. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006; 113: 2335-62. (Review)
    • (2006) Circulation , vol.113 , pp. 2335-2362
    • Vasan, R.S.1
  • 9
    • 44449133317 scopus 로고    scopus 로고
    • Molecular markers for cardiovascular disease: Cardiovascular biomarkers to proteomic discovery
    • Suzuki T, Nagai R. Molecular markers for cardiovascular disease: cardiovascular biomarkers to proteomic discovery. Nat Clin Pract Cardiovasc Med 2008; 5: 295.
    • (2008) Nat Clin Pract Cardiovasc Med , vol.5 , pp. 295
    • Suzuki, T.1    Nagai, R.2
  • 10
    • 61849099312 scopus 로고    scopus 로고
    • Endothelial function predicts progression of carotid intima-media thickness
    • Halcox JP, Donald AE, Ellins E, et al. Endothelial function predicts progression of carotid intima-media thickness. Circulation 2009; 119: 1005-12.
    • (2009) Circulation , vol.119 , pp. 1005-1012
    • Halcox, J.P.1    Donald, A.E.2    Ellins, E.3
  • 11
    • 0344444877 scopus 로고    scopus 로고
    • Case definitions for acute coronary heart disease in epidemiology and clinical research studies: A statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute
    • Luepker RV, Apple FS, Christenson RH, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003; 108: 2543-9.
    • (2003) Circulation , vol.108 , pp. 2543-2549
    • Luepker, R.V.1    Apple, F.S.2    Christenson, R.H.3
  • 12
    • 31944438586 scopus 로고    scopus 로고
    • Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose
    • Tomiyama H, Hashimoto H, Hirayama Y, et al. Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose. Hypertension 2006; 47: 180-8.
    • (2006) Hypertension , vol.47 , pp. 180-188
    • Tomiyama, H.1    Hashimoto, H.2    Hirayama, Y.3
  • 13
    • 58249090244 scopus 로고    scopus 로고
    • Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease
    • Kitta Y, Obata JE, Nakamura T, et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol 2009; 53: 323-30.
    • (2009) J Am Coll Cardiol , vol.53 , pp. 323-330
    • Kitta, Y.1    Obata, J.E.2    Nakamura, T.3
  • 14
    • 77953809302 scopus 로고    scopus 로고
    • The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: Principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: A randomized trial
    • Katakami N, Kim YS, Kawamori R, Yamasaki Y. The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial. Circulation 2010; 121: 2584-91.
    • (2010) Circulation , vol.121 , pp. 2584-2591
    • Katakami, N.1    Kim, Y.S.2    Kawamori, R.3    Yamasaki, Y.4
  • 15
    • 67649760300 scopus 로고    scopus 로고
    • Higher brachial-ankle pulse wave velocity as an independent risk factor for future microalbuminuria in patients with essential hypertension: The J-TOPP study
    • J-TOPP study group
    • Munakata M, Miura Y, Yoshinaga K, J-TOPP study group. Higher brachial-ankle pulse wave velocity as an independent risk factor for future microalbuminuria in patients with essential hypertension: the J-TOPP study. J Hypertens 2009; 27: 1466-71.
    • (2009) J Hypertens , vol.27 , pp. 1466-1471
    • Munakata, M.1    Miura, Y.2    Yoshinaga, K.3
  • 16
    • 0037606203 scopus 로고    scopus 로고
    • Detection of endothelial dysfunction with brachial artery ultrasound scanning
    • (Review)
    • Faulx MD, Wright AT, Hoit BD. Detection of endothelial dysfunction with brachial artery ultrasound scanning. Am Heart J 2003; 145: 943-51. (Review)
    • (2003) Am Heart J , vol.145 , pp. 943-951
    • Faulx, M.D.1    Wright, A.T.2    Hoit, B.D.3
  • 17
    • 43049181357 scopus 로고    scopus 로고
    • Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation
    • Donald AE, Halcox JP, Charakida M, et al. Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation. J Am Coll Cardiol 2008; 51: 1959-64.
    • (2008) J Am Coll Cardiol , vol.51 , pp. 1959-1964
    • Donald, A.E.1    Halcox, J.P.2    Charakida, M.3
  • 18
    • 58849128609 scopus 로고    scopus 로고
    • The relationships of cardiovascular disease risk factors to flow-mediated dilatation in Japanese subjects free of cardiovascular disease
    • Tomiyama H, Matsumoto C, Yamada J, et al. The relationships of cardiovascular disease risk factors to flow-mediated dilatation in Japanese subjects free of cardiovascular disease. Hypertens Res 2008; 31: 2019-25.
    • (2008) Hypertens Res , vol.31 , pp. 2019-2025
    • Tomiyama, H.1    Matsumoto, C.2    Yamada, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.